Back to CVE records
Medium 4.6HealthcarePublished Dec 14, 2018

CVE-2018-18984Medtronic 9790, 2090 CareLink, and 29901 Encore Programmers Missing Encryption of Sensitive Data

Updated under an hour ago ()

Does this affect you?

It affects Medtronic CareLink 9790 Programmer and 5 other products. Add what you run to find out whether that includes you.

EPSS puts the chance of exploitation in the next 30 days at 0.32%, higher than 23% of scored CVEs.

Medtronic CareLink and Encore Programmers do not encrypt or do not sufficiently encrypt sensitive PII and PHI information while at rest .

CVSS
4.6 MEDIUM (v3.1, CNA)CVSS:3.1/AV:P/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
Weakness (CWE)
CWE-311
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
0.32% (percentile 23)
Assigned by
icscert
NVD analysis
Modified
Record last updated
May 22, 2025
First seen by InfoSec Signals
Oct 12, 2026

Affected products

Affected products
Medtronic CareLink 9790 Programmer
medtronic:carelink_9790_programmer (from the name)
all versions
CNA record
Medtronic CareLink 2090 Programmer
medtronic:carelink_2090_programmer (from the name)
all versions
CNA record
Medtronic 29901 Encore Programmer
medtronic:29901_encore_programmer (from the name)
all versions
CNA record
medtronic carelink_2090_programmer_firmware
medtronic:carelink_2090_programmer_firmware
all versions
NVD
medtronic carelink_9790_programmer_firmware
medtronic:carelink_9790_programmer_firmware
all versions
NVD
medtronic 29901_encore_programmer_firmware
medtronic:29901_encore_programmer_firmware
all versions
NVD

References

  • third-party-advisory, us-government-resource
  • vdb-entry, third-party-advisory

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.